Simvastatin and Skin odor abnormal - a phase IV clinical study of FDA data

Summary:

Skin odor abnormal is reported as a side effect among people who take Simvastatin (simvastatin), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Aspirin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Skin odor abnormal when taking Simvastatin. It is created by eHealthMe based on reports of 249,370 people who have side effects when taking Simvastatin from the FDA, and is updated regularly.

What is Simvastatin?

Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,970 Simvastatin users. Check the latest studies of Simvastatin.

What is Skin odor abnormal?

Skin odor abnormal is found to be associated with 449 drugs and 549 conditions by eHealthMe. Check the latest studies of Skin odor abnormal.

On Aug, 11, 2026

249,370 people reported to have side effects when taking Simvastatin.
Among them, 65 people (0.03%) have Skin odor abnormal.

Could Simvastatin cause Skin odor abnormal?

Among these 65 people:

How long have people been on Simvastatin when they have Skin odor abnormal? *

What is the gender of people who have Skin odor abnormal when taking Simvastatin? *

female: 62.3 %
male: 37.7 %

What is the age of people who have Skin odor abnormal when taking Simvastatin? *

What are other drugs people take besides Simvastatin? *

What are other side effects people have besides Skin odor abnormal? *

Headache (pain in head): 17 people, 26.15%
Dizziness: 17 people, 26.15%
Haematuria (presence of blood in urine): 16 people, 24.62%
Oropharyngeal Pain: 15 people, 23.08%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 15 people, 23.08%
Night Sweats (sweating in night): 15 people, 23.08%
Rashes (redness): 14 people, 21.54%
Pain: 13 people, 20.00%
Weakness: 13 people, 20.00%
Back Pain: 12 people, 18.46%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 11 people, 16.92%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 8 people, 12.31%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 7 people, 10.77%
Depression: 7 people, 10.77%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 10.77%
Prostate Cancer: 5 people, 7.69%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 6.15%
Stress And Anxiety: 4 people, 6.15%
Neuropathy Peripheral (surface nerve damage): 3 people, 4.62%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 4.62%

* Approximation only. Some reports may have incomplete information.

Do you take Simvastatin and have Skin odor abnormal?

- Check whether Skin odor abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Simvastatin:

Simvastatin (256,970 reports)

Browse all side effects of Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin odor abnormal:

Skin odor abnormal (449 drugs)

Browse all the conditions that are associated with Skin odor abnormal:

Skin odor abnormal (549 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on simvastatin (the active ingredients of Simvastatin) and Simvastatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.